Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Swiss Vision Network
To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.
Follow-up period is 2 years.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Mild to moderate glaucoma patients
Have given written informed consent
Aged 18 years or older of either sex
You may not be if
Patients not able to understand the character of the study
Participation in other clinical research within the last 4 weeks
Patients with end-stage glaucoma
Patients with glaucoma surgery done before
Clareo Health | Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent
